CT measurements tend to overestimate tumor size, and excessive overestimation (difference >3 mm) was independently associated with higher postoperative recurrence risk. Incorporating CT-pathology discrepancies into prognostic models may improve postoperative risk stratification.
Lu et al. (Sun,) studied this question.